[
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Patients who had the first GOC discussion more than 30 days before death\nwere less likely to die in a hospital (34·9% vs. 59·9%,\np=0·0002; unadjusted OR=0·36 [95% CI 0·21, 0·62]; Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Similarly, patients whose first GOC\ndiscussions took place in the outpatient setting were less likely to have a hospital\ndeath (25·3% vs. 65·6%, p<0.0001; unadjusted OR 0·18\n[95% CI 0.10 to 0·32]; Figure 2), as\nwere patients who had a hematologic oncologist present at their first GOC\nconversation (40·5% vs. 61·2%, p=0·001; unadjusted OR\n=0·43 [95% CI 0·26 to 0·72]; Figure 3, Supplemental\nTable 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We observed no significant differences\nin chemotherapy receipt close to death based on timing or location of first GOC\ndiscussion, or the presence of a hematologic oncologist (Figure 1–3,\nSupplemental Table\n3).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  }
]